Leadership & Pay ·
Dr. Gorjan Hrustanovic resigns from Olema Pharmaceuticals board effective Oct 14
OLMAOlema Pharmaceuticals, Inc.
Olema Pharmaceuticals announced that Dr. Gorjan Hrustanovic resigned from its Board of Directors and its Compensation and Science and Technology Committees, effective October 14, 2026. The company stated the resignation was not due to any disagreement regarding operations or policies. Additionally, the board appointed Dr. Prakash Raman to the Compensation and Science and Technology committees on October 15, 2026. Olema Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapies for cancer.